On the contrary, patients with gastric [32] and breast cancer [33] showed up-regulation of CD95 expression in peripheral blood CD8 Т cells, while head and neck cancer patients displayed increased numbers of CD95+ cells in both CD4 T helper and CD8 T killer subsets [4]. This evidence concerns the gene FAS and head and neck cancer.